Director Andrew Dignan sells 8,203 shares (NASDAQ: FIVN) under 10b5-1 plan
Rhea-AI Filing Summary
Andrew Dignan reported sales of Common Stock under a 10b5-1 plan. The filing lists two dispositions: 5,645 shares sold on 06/04/2026 for $139,656.17 and 2,558 shares sold on 06/03/2026 for $63,463.98. The securities include Restricted Stock Units dated 03/04/2024.
Positive
- None.
Negative
- None.
Insights
Insider completed routine sales under a 10b5-1 arrangement.
The filing shows two reported dispositions by Andrew Dignan executed on 06/03/2026 and 06/04/2026, totaling 8,203 shares and proceeds of $203,120.15. The transactions are labeled as 10b5-1 Sales, indicating they were effected under a prearranged trading plan.
Cash‑flow treatment and remaining holdings are not detailed in the excerpt; subsequent filings may provide position totals or additional context.
Key Figures
Key Terms
10b5-1 regulatory
Restricted Stock Units financial
Common financial
AI-generated analysis. How Rhea-AI works. Not financial advice.